Advertisement
MBGNF vs NNCSF
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MBGNF is a Hold and NNCSF is a Hold.
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
MBGNF’s FA Score shows that 0 FA rating(s) are green whileNNCSF’s FA Score has 0 green FA rating(s).
- MBGNF’s FA Score: 0 green, 5 red.
- NNCSF’s FA Score: 0 green, 5 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
NNCSF’s TA Score shows that 3 TA indicator(s) are bullish.
- NNCSF’s TA Score: 3 bullish, 5 bearish.
Price Growth
MBGNF (@Medical Specialties) experienced а 0.00% price change this week, while NNCSF (@Pharmaceuticals: Other) price change was -14.75% for the same time period.
The average weekly price growth across all stocks in the @Medical Specialties industry was +0.42%. For the same industry, the average monthly price growth was +6.99%, and the average quarterly price growth was +11.90%.
The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was -1.55%. For the same industry, the average monthly price growth was +6.80%, and the average quarterly price growth was +18.40%.
Industries' Descriptions
@Medical Specialties (+0.42% weekly)Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.
@Pharmaceuticals: Other (-1.55% weekly)Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.
| MBGNF | NNCSF | MBGNF / NNCSF | |
| Capitalization | 188K | 807M | 0% |
| EBITDA | -53.72K | 28.2M | -0% |
| Gain YTD | 0.000 | 23.810 | - |
| P/E Ratio | N/A | 59.63 | - |
| Revenue | 0 | 186M | - |
| Total Cash | 217 | N/A | - |
| Total Debt | N/A | N/A | - |
MBGNF | NNCSF | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 23 | 94 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 100 Overvalued | 98 Overvalued | |
PROFIT vs RISK RATING 1..100 | 100 | 100 | |
SMR RATING 1..100 | 100 | 72 | |
PRICE GROWTH RATING 1..100 | 71 | 52 | |
P/E GROWTH RATING 1..100 | 61 | 74 | |
SEASONALITY SCORE 1..100 | 65 | n/a |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
NNCSF's Valuation (98) in the null industry is in the same range as MBGNF (100). This means that NNCSF’s stock grew similarly to MBGNF’s over the last 12 months.
NNCSF's Profit vs Risk Rating (100) in the null industry is in the same range as MBGNF (100). This means that NNCSF’s stock grew similarly to MBGNF’s over the last 12 months.
NNCSF's SMR Rating (72) in the null industry is in the same range as MBGNF (100). This means that NNCSF’s stock grew similarly to MBGNF’s over the last 12 months.
NNCSF's Price Growth Rating (52) in the null industry is in the same range as MBGNF (71). This means that NNCSF’s stock grew similarly to MBGNF’s over the last 12 months.
MBGNF's P/E Growth Rating (61) in the null industry is in the same range as NNCSF (74). This means that MBGNF’s stock grew similarly to NNCSF’s over the last 12 months.
| MBGNF | NNCSF | |
|---|---|---|
| RSI ODDS (%) | N/A | 2 days ago 56% |
| Stochastic ODDS (%) | N/A | 2 days ago 56% |
| Momentum ODDS (%) | N/A | 2 days ago 40% |
| MACD ODDS (%) | N/A | 2 days ago 46% |
| TrendWeek ODDS (%) | 2 days ago 12% | 2 days ago 58% |
| TrendMonth ODDS (%) | 2 days ago 11% | 2 days ago 43% |
| Advances ODDS (%) | N/A | N/A |
| Declines ODDS (%) | N/A | N/A |
| BollingerBands ODDS (%) | N/A | 2 days ago 56% |
| Aroon ODDS (%) | N/A | 2 days ago 43% |
Advertisement
MBGNF and
Correlation & Price change
A.I.dvisor tells us that MBGNF and IDTA have been poorly correlated (+30% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that MBGNF and IDTA's prices will move in lockstep.
| Ticker / NAME | Correlation To MBGNF | 1D Price Change % | ||
|---|---|---|---|---|
| MBGNF | 100% | N/A | ||
| IDTA - MBGNF | 30% Poorly correlated | N/A | ||
| NVYTF - MBGNF | 26% Poorly correlated | N/A | ||
| RYLPF - MBGNF | 24% Poorly correlated | +1.36% | ||
| BIO - MBGNF | 24% Poorly correlated | +0.48% | ||
| VNRX - MBGNF | 22% Poorly correlated | -4.53% | ||
More | ||||
NNCSF and
Correlation & Price change
A.I.dvisor tells us that NNCSF and MBGNF have been poorly correlated (+23% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that NNCSF and MBGNF's prices will move in lockstep.
| Ticker / NAME | Correlation To NNCSF | 1D Price Change % | ||
|---|---|---|---|---|
| NNCSF | 100% | N/A | ||
| MBGNF - NNCSF | 23% Poorly correlated | N/A | ||
| NHNKY - NNCSF | 8% Poorly correlated | +0.48% | ||
| NVYTF - NNCSF | 7% Poorly correlated | N/A | ||
| POCI - NNCSF | 1% Poorly correlated | -0.20% | ||
| MCRPF - NNCSF | 1% Poorly correlated | N/A | ||
More | ||||